About CarBio Therapeutics
CarBio Therapeutics is a company based in Cheongju-si (South Korea) founded in 2022. It operates as a B2B and R&D Licensing. CarBio Therapeutics offers products and services including CAR-T Cell Therapy. CarBio Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cheongju-si, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name (주)카바이오테라퓨틱스
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CarBio Therapeutics
CarBio Therapeutics offers a comprehensive portfolio of products and services, including CAR-T Cell Therapy.
Engineered T cells for targeted disease treatment and immune response.
Funding Insights of CarBio Therapeutics
Investments & Acquisitions by CarBio Therapeutics
Financial Statements - CarBio Therapeutics
Carbio Therapeutics Comparisons
Competitors of CarBio Therapeutics
CarBio Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
Latest news on Carbio Therapeutics
Frequently Asked Questions about CarBio Therapeutics
CarBio Therapeutics was founded in 2022.
CarBio Therapeutics is headquartered in Cheongju-si, South Korea. It is registered at Cheongju-si, North Chungcheong, South Korea.
Carbio Therapeutics focuses on developing innovative CAR-T cell therapies to treat serious diseases by engineering immune cells. The company conducts research, secures investments, and collaborates on clinical advancements. Based in Cheongju, South Korea, it aims to provide effective treatments through partnerships with healthcare entities. Their activities include research pipelines, investor relations, and policy engagements to advance biotechnology.
CarBio Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
CarBio Therapeutics offers CAR-T Cell Therapy.